EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Ultrasound-guided high-intensity focused ultrasound for symptomatic uterine fibroids: clinical outcome of two European centers

Sara Dohmen, Florian Recker, Yoana Ivanova, Holger M Strunk, Tolga Tonguc, Olga Ramig, Marcus Thudium, Judith M Stader, Rupert Conrad, Markus Essler, Eva-Katharina Egger, Alexander Mustea und 3 weitere

European Radiology · 29.11.2024 · 35 (6) · 3638-3648

DOI: 10.1007/s00330-024-11230-4 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Radiology, online erschienen am 29.11.2024. Verfasst von Sara Dohmen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Leiomyoma, High-Intensity Focused Ultrasound Ablation, Uterine Neoplasms, Ultrasonography, Interventional. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of this study is to assess the clinical outcome and mid-term efficacy of ultrasound-guided high-intensity focused ultrasound (USgHIFU) as a treatment for symptomatic uterine fibroids at two major European HIFU centers. Materials and methods This bi-center longitudinal clinical study involved the treatment of 100 patients with symptomatic uterine fibroids using USgHIFU ( n = 59 in Germany, n = 41 in Bulgaria). Clinical outcomes were evaluated at 6 weeks, 6 months, and 1 year follow-up utilizing the uterine fibroid symptoms-quality of life questionnaire for fibroid-related symptoms and health-related quality of life as well as MRI imaging for determining the fibroid volume.

Results

The mean fibroid volume reduction rate was 33.2 ± 22.9%, 51.3 ± 24.2%, and 59.1 ± 28.0% at 6 weeks, 6 months, and 1 year, respectively (each p < 0.001). The mean symptom severity score decreased from 43.9 ± 18.8 at baseline to 35.4 ± 18.2 at 6 weeks, 31.1 ± 20.0 at 6 months, and 23.1 ± 14.0 at 1 year (each p < 0.001). The mean QOL score improved from 56.5 ± 23.4 at baseline to 65.4 ± 22.2 at 6 weeks, 72.5 ± 19.5 at 6 months, and 79.4 ± 15.3 at 1 year (each p < 0.001). No major complications were observed, though two patients experienced temporary sciatic nerve irritation following the procedure. Four patients had pregnancies and deliveries without any complications after USgHIFU therapy.

Conclusion

To our knowledge, this is the first longitudinal study conducted in two major European HIFU centers that reveals the clinical efficacy of USgHIFU ablation on symptomatic uterine fibroids. Our results confirm that USgHIFU is a non-invasive approach with a low risk of complications, offering an innovative treatment option for affected women. Key Points Question To evaluate mid-term clinical efficacy and safety of US-guided high-intensity focused ultrasound (HIFU) for treating symptomatic uterine fibroids and patient outcomes across two European centers.

Findings

US-guided HIFU treatment resulted in significant fibroid volume reduction (up to 59.1% after 1 year) improving symptoms and quality of life with no major complications. Clinical relevance This prospective longitudinal study provides preliminary data assessing mid-term efficacy and clinical outcomes of ultrasound-guided HIFU. It is shown to be a low-risk, non-invasive treatment option for symptomatic uterine fibroids that reduces fibroid size and improves patients’ quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeiomyomaHigh-Intensity Focused Ultrasound AblationUterine NeoplasmsUltrasonography, InterventionalHumansFemaleAdultTreatment OutcomeQuality of LifeMiddle AgedLongitudinal StudiesGermanyBulgariaMagnetic Resonance Imaging

Stichwörter der Autor:innen

Fibroid-related symptomsHealth-related quality of lifeHigh-intensity focused ultrasound (HIFU)Non-invasive treatment optionSymptomatic uterine fibroids

Autor:innen und Institutionen

  • Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
  • Department of Rаdiology, University Hospital Bonn, Bonn, Germany.
  • Department of Gynaecology and Gynaecological Oncology, University Hospital Bonn, Bonn, Germany.
  • Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Bonn, Germany.
  • St. Marina University Hospital, Medical University Pleven, Pleven, Bulgaria.
  • University of Bonn, Bonn, Germany.

Zitieren

APA

Dohmen, S., Recker, F., Ivanova, Y., Strunk, H. M., Tonguc, T., Ramig, O., Thudium, M., Stader, J. M., Conrad, R., Essler, M., Egger, E. K., Mustea, A., Gortchev, G. A., Dimitrov, D., & Marinova, M. (2024). Ultrasound-guided high-intensity focused ultrasound for symptomatic uterine fibroids: clinical outcome of two European centers. European Radiology, 35(6), 3638-3648. https://doi.org/10.1007/s00330-024-11230-4

Vancouver

Dohmen S, Recker F, Ivanova Y, Strunk HM, Tonguc T, Ramig O, et al. Ultrasound-guided high-intensity focused ultrasound for symptomatic uterine fibroids: clinical outcome of two European centers. European Radiology. 2024;35(6):3638-3648. doi:10.1007/s00330-024-11230-4

BibTeX
@article{Dohmen2024,
  author = {Dohmen, Sara and Recker, Florian and Ivanova, Yoana and Strunk, Holger M and Tonguc, Tolga and Ramig, Olga and Thudium, Marcus and Stader, Judith M and Conrad, Rupert and Essler, Markus and Egger, Eva-Katharina and Mustea, Alexander and Gortchev, Grigor A and Dimitrov, Dobromir and Marinova, Milka},
  title = {Ultrasound-guided high-intensity focused ultrasound for symptomatic uterine fibroids: clinical outcome of two European centers},
  journal = {European Radiology},
  year = {2024},
  volume = {35},
  number = {6},
  pages = {3638--3648},
  doi = {10.1007/s00330-024-11230-4}
}
Kostenlos starten →